Tarts, Lefatta and Lipitor M enter their salary next month – Medication News



[ad_1]

Repeta, a homozygous familial hypercholesterolemia treatment (component name: Ebolocumum, Amgen), which was pointed out that the effect is halved because it is not covered by the benefits of health insurance despite the application of the exemption, is finally entered on the payroll

The inhibitor of the IL-17A Tatsu (Ingredient Iksecjumat, Lilly) is also on the pay line, and options for treating severe psoriasis are expected to diversify

The Ministry of Health and Welfare (Ministry of Health and Welfare Announcement No. 2018-490) to revise the notification details of the standard of application and method of medical care benefits (drugs), which contains the same content,

▲ Talies on the treatment of Lili scalp psoriasis

According to the Amendment, talc is paid on patients with severe sclerosis chronic (adults over 18 years) who last more than 6 months.

Patients with psoriasis accounted for more than 10% of body surface area, severity and severity of psoriasis (PASI) score of 10 or greater, and no response or side effect even though MTX (methotrexate) or cyclosporine was administered for more than 3 months. Or if treatment can not be continued due to lack of response or side effects, even if the treatment has been treated for 3 months or more with PUVA or UVB treatment.

Photochemistry of the skin

If PASI is reduced by more than 75% after 12 weeks of use, it is recommended to administer an additional 6 months of treatment.

Inhibitor alpha tumor necrosis factor (TNF-α inhibitor), or a combination of both, there is no effect on the injection or s & # 39; 39, it is not possible to continue the drug because of side effects, or it is necessary to improve the compliance of drugs (drugs that have been replaced, moreover , the patient should be advised to keep the drug for at least six months, in which case the tactic should be accompanied by a report on the administration of the replacement product

.

However, in the case of a long-term prescription, it is recommended to prescribe up to 4 weeks in case of going out of a prescription period or in case of outpatient prescription.

In patients with stable activity of the disease after weeks and no side effects, up to 8 to 12 weeks are allowed

▲ Amphotericin,

Treatment of familial hypercholesterolemia Reptado PCSK9 inhibitors are also the first to offer a wage standard.

The subjects were subjects with homozygous familial hypercholesterolemia in children and adults aged 12 years or older. If the LDL-C level is not more than 50% lower than the reference value or if the LDL-C level is 70 mg / dL or more, dL).

The combination product atorvastatin / metformin (product name: Lipitor M, etc.) also enters the payroll.

Zoledronic acid injections are used in patients with postmenopausal osteoporosis (△ 65 years or older) with one or more femoral fractures or two or more vertebral fractures. Patients with osteoporotic fractures were X-ray confirmed If the T-score was less than -2.5 (QCT 80 mg / ㎤) or an osteoporotic fracture occurred during follow-up,

The use of infliximab, such as Remicade, in the treatment of gangrenous granulomatous disease (dose: 5 mg / kg), which does not respond to steroids and oral cyclosporine agents,

Injections of pentamidine diethionate were approved up to three times total, although they had to bear the full cost of the drug. The patient had to pay the entire drug in high-risk patients who needed a pneumonia prevention (transplantation, AIDS, chemotherapy, etc.), but the amendment also allowed them to recognize the benefits. medical.

Centreless (drug name: Raltegravir, MSD), an HIV treatment that has been granted only to adult patients, is subject to a wider range of benefits for adults and pediatricians aged 6 years and more, like the license

< 저작권자 © 의약뉴스 무단전재 및 재배포금지 >

[ad_2]
Source link